(Q43540311)

24 November 2017

title

A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers (English)

1 reference

24 November 2017

1 reference

Blode H

1

1 reference

24 November 2017

Wuttke W

2

1 reference

24 November 2017

Loock W

3

1 reference

24 November 2017

Röll G

4

1 reference

24 November 2017

Heithecker R

5

1 reference

24 November 2017

publication date

1 December 2000

1 reference

The European Journal of Contraception Reproductive Health Care

24 November 2017

published in

1 reference

24 November 2017

volume

5

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

256-264

1 reference

Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels i

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180008500407

10.1080/13625180008500407

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference